Evidence map›Paper›PMID 35900132›Full record

ReviewAnnals of medicine2022

Addressing adolescent substance use with a public health prevention framework: the case for harm reduction.

James Michael Winer, Amy M Yule, Scott E Hadland, Sarah M Bagley

Open access · goldAbstract readReview
In one paragraph

Review in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Keepin' It REAL-Mantente REAL in Mexico: Longitudinal Examination of Youth Drug Resistance Strategies and Substance Use Among Early Adolescents.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Substance Use Screening Among Adolescents: National Dental Practice-Based Research Network Survey.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. A Narrative Review of Nicotine and Alcohol Addiction Recovery Content on TikTok.Journal of the Korean Academy of Child and Adolescent Psychiatry · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Exploring Support Preferences for Young Women Who Self-Harm: A Qualitative Study.International journal of environmental research and public health · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

James Michael WinerSection of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Amy M YuleGrayken Center for Addiction, Boston Medical Center, Boston, MA, USA.
Scott E HadlandDivision of Adolescent and Young Adult Medicine, MassGeneral Hospital for Children, Boston, MA, USA.
Sarah M BagleySection of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0002-7524-0178
Boston University · USHarvard University · US

Funding

Collaborative Care Office-Based Opioid Treatment for Adolescents and Young AdultsK23DA045085 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HADLAND, SCOTT EVAN · 2018 to 2022
$1.1M
NIDA NIH HHS K23 DA045085
6 · The paper itself

Abstract

Adolescence is a developmental stage defined in part by risk-taking. Risk-taking is critical to normal development and has important benefits including trying new activities and exploring new relationships. Risk-taking is also associated with the initiation of substance use. Because substance use often begins in adolescence, much focus has been on primary prevention with the goal of preventing initial substance use. Secondary or tertiary prevention approaches, such as counselling to eliminate substance use or offering treatment, are common approaches for adolescents with problematic substance use or a substance use disorder. While this is important, for some adolescents, treatment or cessation of use may not be desired. In these cases, Healthcare Practitioners (HCPs) can offer clear advice that incorporates harm reduction. Harm reduction, which is often applied for adults who use substances, reduces the negative impacts associated with drug use without requiring abstinence. Harm reduction is crucial to keeping adolescents safe and healthy and can offer opportunities for future engagement in treatment. The objective of this review is to describe strategies for integrating harm reduction principles in clinical settings that are developmentally appropriate. A patient-centered, harm reduction approach can validate perceived benefits of substance use, offer strategies to minimise harm, and advise reduction of use and abstinence.KEY MESSAGES:Substance use often begins in adolescence and traditional approaches are often rooted in prevention framework.Harm reduction should be incorporated for adolescents with problematic substance use or a substance use disorder.This review offers strategies for integration of harm reduction principles tailored towards adolescents.

Indexed as

Harm ReductionSubstance-Related DisordersAdolescentHumansPublic HealthaddictionAdolescentsharm reductionsubstance use disorder

Identifiers

PMID35900132
PMCPMC9341337
OpenAlexW4288431986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.